Product
Isoniazid/Pyridoxine
1 clinical trial
2 indications
Indication
TuberculosisIndication
Systemic Lupus ErythematosusClinical trial
Study on the Safety of Administering Isoniazid to Systemic Lupus Erythematosus Patients to Prevent TuberculosisStatus: Recruiting, Estimated PCD: 2025-12-01